Supply. It involves many issues including market structures. And we could go on and on. Substitution possibilities, etc. But but what we tackled so far were the difficult issues of things like helping ukraine face the winter, etc. This year and that will continue. But this year frankly a harder issue. We are due to report onto the g7 leader summit. And that is a real intermediate to longterm plan for integrated collective Energy Security. And that gets into some very fundamental policy issues in different countries. But that will be a big agenda item for this year. Finally let me say a few words on the quadrennial Energy Review. I have to say a few words about it first. Some of you are familiar and some are not. This is an admissionwide effort that is looking to weave together all of the equities and threads of an Energy Policy across the government. The first of the quadrennial. It to us its one plus one plus one plus one. And in the first one, we are focussing on energy structure. Tr
The physician payment sunshine act. It was a bipartisan piece of legislationo senate by senatorrofz grassley. Republican from iowa. And senator herb kohl a democrat from wisconsin. And the bill sought to lift the veil on the relationship between industry and it was a true piece of Bipartisan Legislation that was founded on a lot of the research that youre going to hear from some of our great speakers today. It was written in conjunction z with the information that we gotrcd from the research community, and the consumer community, represented by pew and allen here today and aarp and amsa and me concerned that these r b2bk ; relationships, the Financial Relationships, were impacting both the quality of health care, and the cost of health care. J2. Sn and i have to say that the process was long and tireless. At the time i worked for senator herb cole and we had, with my colleague Chris Armstrong from oa senator grassleys office, about 300 meetings with consumer a d z tr t hahp hc groups,
3. 7 billion in payments to p n hospitals in fiveu r months of the first year of reporting. Thats a÷n1szw eajjr hvqp . Those are funds that are either going to research and product development, and thats important and important for the public to understand. Or going to drive uptake of particular products. Thats also important and important to understand. eb÷ so where are we now . Pew has been involved in this acs issue in a long time, as have the other folks on the pafj0o today, and many other organizations. And since passage we have s continued tkgf hp orking group of consumer organizations, and also individual companies to build shared understanding about how the data should be presented. And about some of the technical challenges in getting that data d,s7÷ . uujeu q ublic domain. Data for the first full year of reporting has been collected. 2014 data has been collected. It will be submitted to cms in march. And in june we will have publication of the first full ÷ bko year ofut9
A spiritual advisor of the 9 11 bombers. This is not some extraneous person. This is someone who is a major in the militarys communicating by email within. Despite all of our surveillance capabilities, we failed to prevent that horrific that claimed the lives of 14 innocents. In your judgment, what could we have done better to prevent that . To be honest, i will answer that question to senator graham. The that may suggest more broadly on both of these that it would be a far better allocation of resources in the nsa and our efforts to prevent terrorism generally as much by resources were big to targeting those who we have reason to know are dangerous. We have reasons to know the islamic terrorist and have less resources were devoted to broderick intersection and her valence of lawabiding citizens. It is to me for some time that the priorities have been backwards and we had to be targeting the bad guys than protect innocents from terrorist attacks and at the same time respecting the Cons
And also one of the things that excites me is developing computer simulations and models so that you can actually study some of these devices in that context instead of in animal models or people in the early stages so that you can really number one manipulate things and play with it more but also reduce costs and potential risks to patients but still really get import information to again moved things that have promise into the marketplace and making a difference in peoples lives. So i think its a wonderful public credit partnership. Thank you for your leadership in helping to make it possible and we are very committed to working with it read we are seeing the benefits already and we see more importantly a foundation for lots more progress. Well thank you for your role in that and for your excitement about it. Senator enzi. Thank you mr. Chairman. I would like to revisit the goals you immediately identified when he took the helm at the fda modernizing how the agency considers new ther